Product Code: TMRGL84817
The report provides revenue of the global cat allergy in humans market for the period 2017-2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global cat allergy in humans market from 2022 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the cat allergy in humans market.
The report delves into the competitive landscape of the global cat allergy in humans market. Key players operating in the global cat allergy in humans market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global cat allergy in humans market profiled in this report.
Table of Contents
1. Preface
- 1.1. Market Definition and Scope
- 1.2. Market Segmentation
- 1.3. Key Research Objectives
- 1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary : Global Cat Allergy in Humans Market
4. Market Overview
- 4.1. Introduction
- 4.1.1. Definition
- 4.1.2. Industry Evolution / Developments
- 4.2. Overview
- 4.3. Market Dynamics
- 4.3.1. Drivers
- 4.3.2. Restraints
- 4.3.3. Opportunities
- 4.4. Global Cat Allergy in Humans Market Analysis and Forecasts, 2017-2031
5. Key Insights
- 5.1. Key Mergers & Acquisitions
- 5.2. Allergy Prevalence Data
- 5.3. Pipeline Analysis
- 5.4. COVID-19 Pandemic Impact on Industry (Value Chain and Short / Mid / Long Term Impact)
6. Global Cat Allergy in Humans Market Analysis and Forecasts, By Treatment
- 6.1. Introduction & Definition
- 6.2. Key Findings / Developments
- 6.3. Market Value Forecast By Treatment, 2017-2031
- 6.3.2. Corticosteroid Nasal Sprays
- 6.3.3. Decongestants
- 6.3.4. Leukotriene Inhibitors
- 6.3.5. Others
- 6.4. Market Attractiveness By Treatment
7. Global Cat Allergy in Humans Market Analysis and Forecasts, By Application
- 7.1. Introduction & Definition
- 7.2. Key Findings / Developments
- 7.3. Market Value Forecast By Application, 2017-2031
- 7.3.1. Allergy Treatment
- 7.3.2. Allergy Prevention
- 7.4. Market Attractiveness By Application
8. Global Cat Allergy in Humans Market Analysis and Forecasts, By Distribution Channel
- 8.1. Introduction & Definition
- 8.2. Key Findings / Developments
- 8.3. Market Value Forecast By Distribution Channel, 2017-2031
- 8.3.1. Hospital pharmacies
- 8.3.2. Retail pharmacies
- 8.3.3. Online Pharmacies
- 8.4. Market Attractiveness By Distribution Channel
9. Global Cat Allergy in Humans Market Analysis and Forecasts, By Region
- 9.1. Key Findings
- 9.2. Market Value Forecast By Region
- 9.2.1. North America
- 9.2.2. Europe
- 9.2.3. Asia Pacific
- 9.2.4. Latin America
- 9.2.5. Middle East & Africa
- 9.3. Market Attractiveness By Country/Region
10. North America Cat Allergy in Humans Market Analysis and Forecast
- 10.1. Introduction
- 10.2. Market Value Forecast By Treatment, 2017-2031
- 10.2.1. Antihistamines
- 10.2.2. Corticosteroid Nasal Sprays
- 10.2.3. Decongestants
- 10.2.4. Leukotriene Inhibitors
- 10.2.5. Others
- 10.3. Market Value Forecast By Application, 2017-2031
- 10.3.1. Allergy Treatment
- 10.3.2. Allergy Prevention
- 10.4. Market Value Forecast By Distribution Channel, 2017-2031
- 10.4.1. Hospital pharmacies
- 10.4.2. Retail pharmacies
- 10.4.3. Online Pharmacies
- 10.5. Market Value Forecast By Country, 2017-2031
- 10.5.1. U.S.
- 10.5.2. Canada
- 10.6. Market Attractiveness Analysis
- 10.6.1. By Treatment
- 10.6.2. By Application
- 10.6.3. By Distribution Channel
- 10.6.4. By Country
11. Europe Cat Allergy in Humans Market Analysis and Forecast
- 11.1. Introduction
- 11.2. Market Value Forecast By Treatment, 2017-2031
- 11.2.1. Antihistamines
- 11.2.2. Corticosteroid Nasal Sprays
- 11.2.3. Decongestants
- 11.2.4. Leukotriene Inhibitors
- 11.2.5. Others
- 11.3. Market Value Forecast By Application, 2017-2031
- 11.3.1. Allergy Treatment
- 11.3.2. Allergy Prevention
- 11.4. Market Value Forecast By Distribution Channel, 2017-2031
- 11.4.1. Hospital pharmacies
- 11.4.2. Retail pharmacies
- 11.4.3. Online Pharmacies
- 11.5. Market Value Forecast By Country, 2017-2031
- 11.5.1. Germany
- 11.5.2. U.K.
- 11.5.3. France
- 11.5.4. Italy
- 11.5.5. Spain
- 11.5.6. Rest of Europe
- 11.6. Market Attractiveness Analysis
- 11.6.1. By Treatment
- 11.6.2. By Application
- 11.6.3. By Distribution Channel
- 11.6.4. By Country
12. Asia Pacific Cat Allergy in Humans Market Analysis and Forecast
- 12.1. Introduction
- 12.2. Market Value Forecast By Treatment, 2017-2031
- 12.2.1. Antihistamines
- 12.2.2. Corticosteroid Nasal Sprays
- 12.2.3. Decongestants
- 12.2.4. Leukotriene Inhibitors
- 12.2.5. Others
- 12.3. Market Value Forecast By Application, 2017-2031
- 12.3.1. Allergy Treatment
- 12.3.2. Allergy Prevention
- 12.4. Market Value Forecast By Distribution Channel, 2017-2031
- 12.4.1. Hospital pharmacies
- 12.4.2. Retail pharmacies
- 12.4.3. Online Pharmacies
- 12.5. Market Value Forecast By Country, 2017-2031
- 12.5.1. China
- 12.5.2. Japan
- 12.5.3. India
- 12.5.4. Australia & New Zealand
- 12.5.5. Rest of Asia Pacific
- 12.6. Market Attractiveness Analysis
- 12.6.1. By Treatment
- 12.6.2. By Application
- 12.6.3. By Distribution Channel
- 12.6.4. By Country
13. Latin America Cat Allergy in Humans Market Analysis and Forecast
- 13.1. Introduction
- 13.2. Market Value Forecast By Treatment, 2017-2031
- 13.2.1. Antihistamines
- 13.2.2. Corticosteroid Nasal Sprays
- 13.2.3. Decongestants
- 13.2.4. Leukotriene Inhibitors
- 13.2.5. Others
- 13.3. Market Value Forecast By Application, 2017-2031
- 13.3.1. Allergy Treatment
- 13.3.2. Allergy Prevention
- 13.4. Market Value Forecast By Distribution Channel, 2017-2031
- 13.4.1. Hospital pharmacies
- 13.4.2. Retail pharmacies
- 13.4.3. Online Pharmacies
- 13.5. Market Value Forecast By Country, 2017-2031
- 13.5.1. Brazil
- 13.5.2. Mexico
- 13.5.3. Rest of Latin America
- 13.6. Market Attractiveness Analysis
- 13.6.1. By Treatment
- 13.6.2. By Application
- 13.6.3. By Distribution Channel
- 13.6.4. By Country
14. Middle East & Africa Cat Allergy in Humans Market Analysis and Forecast
- 14.1. Introduction
- 14.2. Market Value Forecast By Treatment, 2017-2031
- 14.2.1. Antihistamines
- 14.2.2. Corticosteroid Nasal Sprays
- 14.2.3. Decongestants
- 14.2.4. Leukotriene Inhibitors
- 14.2.5. Others
- 14.3. Market Value Forecast By Application, 2017-2031
- 14.3.1. Allergy Treatment
- 14.3.2. Allergy Prevention
- 14.4. Market Value Forecast By Distribution Channel, 2017-2031
- 14.4.1. Hospital pharmacies
- 14.4.2. Retail pharmacies
- 14.4.3. Online Pharmacies
- 14.5. Market Value Forecast By Country, 2017-2031
- 14.5.1. GCC Countries
- 14.5.2. South Africa
- 14.5.3. Rest of Middle East & Africa
- 14.6. Market Attractiveness Analysis
- 14.6.1. By Treatment
- 14.6.2. By Application
- 14.6.3. By Distribution Channel
- 14.6.4. By Country
15. Competition Landscape
- 15.1. Market Player - Competition Matrix (by tier and size of companies)
- 15.2. Market Share Analysis, by Company, 2020
- 15.3. Company Profiles
- 15.3.1. Bayer AG
- 15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.1.2. Product Portfolio
- 15.3.1.3. SWOT Analysis
- 15.3.1.4. Strategic Overview
- 15.3.2. Covis Pharma B.V
- 15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.2.2. Product Portfolio
- 15.3.2.3. SWOT Analysis
- 15.3.2.4. Strategic Overview
- 15.3.3. HollisterStier Allergy.
- 15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.3.2. Product Portfolio
- 15.3.3.3. SWOT Analysis
- 15.3.3.4. Strategic Overview
- 15.3.4. GlaxoSmithKline plc
- 15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.4.2. Product Portfolio
- 15.3.4.3. SWOT Analysis
- 15.3.4.4. Strategic Overview
- 15.3.5. Merck & Co. Inc.
- 15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.5.2. Product Portfolio
- 15.3.5.3. SWOT Analysis
- 15.3.5.4. Strategic Overview
- 15.3.6. Regeneron Pharmaceuticals, Inc.
- 15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.6.2. Product Portfolio
- 15.3.6.3. SWOT Analysis
- 15.3.6.4. Strategic Overview
- 15.3.7. Saiba Animal Health AG
- 15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.7.2. Product Portfolio
- 15.3.7.3. SWOT Analysis
- 15.3.7.4. Strategic Overview
- 15.3.8. Sanofi, Stallergenes Greer
- 15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.8.2. Product Portfolio
- 15.3.8.3. SWOT Analysis
- 15.3.8.4. Strategic Overview